Abstract:Ischemic heart disease, which is one of the top killers worldwide, encompasses a series of heart problems stemming from a compromised coronary blood supply to the myocardium. The severity of the disease ranges from an unstable manifestation of ischemic symptoms, such as unstable angina, to myocardial death, that is, the immediate life-threatening condition of myocardial infarction. Even though patients may survive myocardial infarction, the resulting ischemia-reperfusion injury triggers a cascade of inflammatory reactions and oxidative stress that poses a significant threat to myocardial function following successful revascularization. Moreover, despite evidence suggesting the presence of cardiac stem cells, the fact that cardiomyocytes are terminally differentiated and cannot significantly regenerate after injury accounts for the subsequent progression to ischemic cardiomyopathy and ischemic heart failure, despite the current advancements in cardiac medicine. In the last two decades, researchers have realized the possibility of utilizing stem cell plasticity for therapeutic purposes. Indeed, stem cells of different origin, such as bone-marrow- and adipose-derived mesenchymal stem cells, circulation-derived progenitor cells, and induced pluripotent stem cells, have all been shown to play therapeutic roles in ischemic heart disease. In addition, the discovery of stem-cell-associated paracrine effects has triggered intense investigations into the actions of exosomes. Notwithstanding the seemingly promising outcomes from both experimental and clinical studies regarding the therapeutic use of stem cells against ischemic heart disease, positive results from fraud or false data interpretation need to be taken into consideration. The current review is aimed at overviewing the therapeutic application of stem cells in different categories of ischemic heart disease, including relevant experimental and clinical outcomes, as well as the proposed mechanisms underpinning such observations.

Programmed Cell Death of Endothelial Cells in Myocardial Infarction and Its Potential Therapeutic Strategy

Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches

Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion

Regulated cell death pathways in cardiomyopathy

Mechanisms and Therapeutic Potential of Multiple Forms of Cell Death in Myocardial Ischemia–Reperfusion Injury

Regulated cell death in acute myocardial infarction: Molecular mechanisms and therapeutic implications

The Challenges Of Stem Cell Therapy In Myocardial Infarction And Heart Failure And The Potential Strategies To Improve The Outcomes

Programmed Necrosis in Heart Disease: Molecular Mechanisms and Clinical Implications.

Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

Programmed Necrosis in Cardiomyocytes: Mitochondria, Death Receptors and Beyond.

Regulatory T Lymphocytes in Myocardial Infarction: A Promising New Therapeutic Target

Targeting the pathways of regulated necrosis: a potential strategy for alleviation of cardio-cerebrovascular injury

Concise Review: Optimized Strategies for Stem Cell-based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation.

PANoptosis: Novel insight into regulated cell death and its potential role in cardiovascular diseases (Review)

Stem Cell Therapy against Ischemic Heart Disease

Potential drug targets for myocardial infarction identified through Mendelian randomization analysis and Genetic colocalization

Epigenetic Regulation of Diverse Regulated Cell Death Modalities in Cardiovascular Disease:Insights into Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis

Regulated cell death in myocardial ischemia-reperfusion injury

Targeting the Endothelium to Achieve Cardioprotection

Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications

Anti-apoptosis in nonmyocytes and pro-autophagy in cardiomyocytes: two strategies against postinfarction heart failure through regulation of cell death/degeneration